Next Article in Journal
Interaction of Graphene Oxide Nanoparticles with Human Mesenchymal Stem Cells Visualized in the Cell-IQ System
Next Article in Special Issue
Fabrication of Antibacterial and Antioxidant ZnO-Impregnated Amine-Functionalized Chitosan Bio-Nanocomposite Membrane for Advanced Biomedical Applications
Previous Article in Journal
Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury
Previous Article in Special Issue
Multiepitope Subunit Peptide-Based Nanovaccine against Porcine Circovirus Type 2 (PCV2) Elicited High Antibody Titers in Vaccinated Mice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 10
10.3390/molecules28104146
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles

by
Rasha H. Al-Serwi
1,
Mohamed A. Eladl
2,
Mohamed El-Sherbiny
3,4,
Mohamed A. Saleh
5,6,
Gamal Othman
3,
Sultan M. Alshahrani
7,
Rasha Alnefaie
8,
Afnan M. Jan
9,
Sulaiman M. Alnasser
10,
Aishah E. Albalawi
11,
Jamal Moideen Muthu Mohamed
12,* and
Farid Menaa
13,*
1
Department of Basic Dental Sciences, College of Dentistry, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
2
Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
3
Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh 11597, Saudi Arabia
4
Department of Anatomy and Embryology, Faculty of Medicine, Mansoura 35511, Egypt
5
Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
6
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
7
Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia
8
Department of Biology, Faculty of Science, Al-Baha University, Al Baha 65779, Saudi Arabia
9
Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia
10
Department of Pharmacology and Toxicology, Unaizah Colleage of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia
11
Department of Biology, Faculty of Science, University of Tabuk, Tabuk 47913, Saudi Arabia
12
Vaasudhara College of Pharmacy, Rajiv Gandhi University of Health Sciences, Sante Circle, Chintamani Road, Hoskote 562114, Karnataka, India
13
Departments of Medicine and Nanomedicine, California Innovations Corporation, San Diego, CA 92037, USA
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(10), 4146; https://doi.org/10.3390/molecules28104146
Submission received: 2 March 2023 / Revised: 17 April 2023 / Accepted: 11 May 2023 / Published: 17 May 2023
(This article belongs to the Special Issue Nanomaterials for Advanced Biomedical Applications)
Browse Figures
Versions Notes

Abstract

Quercetin (QtN) displays low systemic bioavailability caused by poor water solubility and instability. Consequently, it exerts limited anticancer action in vivo. One solution to increase the anticancer efficacy of QtN is the use of appropriate functionalized nanocarriers that preferentially target and deliver the drug to the tumor location. Herein, a direct advanced method was designed to develop water-soluble hyaluronic acid (HA)-QtN-conjugated silver nanoparticles (AgNPs). HA-QtN reduced silver nitrate (AgNO3) while acting as a stabilizing agent to produce AgNPs. Further, HA-QtN#AgNPs served as an anchor for folate/folic acid (FA) conjugated with polyethylene glycol (PEG). The resulting PEG-FA-HA-QtN#AgNPs (further abbreviated as PF/HA-QtN#AgNPs) were characterized both in vitro and ex vivo. Physical characterizations included UV-visible (UV-Vis) spectroscopy, Fourier transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), particle size (PS) and zeta potential (ZP) measurements, and biopharmaceutical evaluations. The biopharmaceutical evaluations included analyses of the cytotoxic effects on the HeLa and Caco-2 cancer cell lines using the MTT assay; cellular drug intake into cancer cells using flow cytometry and confocal microscopy; and blood compatibility using an automatic hematology analyzer, a diode array spectrophotometer, and an enzyme-linked immunosorbent assay (ELISA). The prepared hybrid delivery nanosystem was hemocompatible and more oncocytotoxic than the free, pure QtN. Therefore, PF/HA-QtN#AgNPs represent a smart nano-based drug delivery system (NDDS) and could be a promising oncotherapeutic option if the data are validated in vivo.
Keywords: water-soluble quercetin; silver nanoparticles; functional polymer–drug conjugates; nanodrug delivery systems; hemocompatibility; cytotoxicity; oncotargets water-soluble quercetin; silver nanoparticles; functional polymer–drug conjugates; nanodrug delivery systems; hemocompatibility; cytotoxicity; oncotargets

Share and Cite

MDPI and ACS Style

Al-Serwi, R.H.; Eladl, M.A.; El-Sherbiny, M.; Saleh, M.A.; Othman, G.; Alshahrani, S.M.; Alnefaie, R.; Jan, A.M.; Alnasser, S.M.; Albalawi, A.E.; et al. Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules 2023, 28, 4146. https://doi.org/10.3390/molecules28104146

AMA Style

Al-Serwi RH, Eladl MA, El-Sherbiny M, Saleh MA, Othman G, Alshahrani SM, Alnefaie R, Jan AM, Alnasser SM, Albalawi AE, et al. Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules. 2023; 28(10):4146. https://doi.org/10.3390/molecules28104146

Chicago/Turabian Style

Al-Serwi, Rasha H., Mohamed A. Eladl, Mohamed El-Sherbiny, Mohamed A. Saleh, Gamal Othman, Sultan M. Alshahrani, Rasha Alnefaie, Afnan M. Jan, Sulaiman M. Alnasser, Aishah E. Albalawi, and et al. 2023. "Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles" Molecules 28, no. 10: 4146. https://doi.org/10.3390/molecules28104146

APA Style

Al-Serwi, R. H., Eladl, M. A., El-Sherbiny, M., Saleh, M. A., Othman, G., Alshahrani, S. M., Alnefaie, R., Jan, A. M., Alnasser, S. M., Albalawi, A. E., Mohamed, J. M. M., & Menaa, F. (2023). Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules, 28(10), 4146. https://doi.org/10.3390/molecules28104146

Article Metrics

Back to TopTop